Biocity Biopharmaceutics Co., Ltd.
Clinical trials sponsored by Biocity Biopharmaceutics Co., Ltd., explained in plain language.
-
New drug duo aims to shrink hard-to-treat tumors
Disease control Recruiting nowThis study tests a new drug called BC3195 combined with pembrolizumab (an immunotherapy) in people with advanced solid tumors that have spread. The goal is to find a safe dose and see if the combination can shrink tumors. About 111 adults with certain cancers will take part.
Phase: PHASE1, PHASE2 • Sponsor: Biocity Biopharmaceutics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New hope for advanced cancer? early trial of BC2027 begins
Disease control Recruiting nowThis early-phase trial is testing a new drug, BC2027, in 180 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the right dose, and see if it can shrink tumors or slow their growth. Participants re…
Phase: PHASE1 • Sponsor: Biocity Biopharmaceutics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC